Biomarker-guided classification scheme of neurodegenerative diseases

被引：18

作者：

Baldacci, Filippo ^{[1
,2
,3
]}

Lista, Simone ^{[4
,5
,6
]}

Garaci, Francesco ^{[7
,8
]}

Bonuccelli, Ubaldo ^{[1
]}

Toschi, Nicola ^{[7
,9
,10
]}

Hampel, Harald ^{[2
,3
,4
,5
]}

机构：

[1] Univ Pisa, Dept Clin & Expt Med, I-56126 Pisa, Italy

[2] Hop La Pitie Salpetriere, Inst Memory & Alzheimers Dis IM2A, Brain & Spine Inst ICM, UMR S 1127,Dept Neurol, F-75651 Paris, France

[3] Pierre & Marie Curie Univ, Sorbonne Univ, Paris VI, F-75005 Paris, France

[4] AXA Res Fund, F-75005 Paris, France

[5] Pierre & Marie Curie Univ Chair, F-75005 Paris, France

[6] Hop La Pitie Salpetriere, IHU A ICM Paris Inst Translat Neurosci, F-75651 Paris, France

[7] Univ Roma Tor Vergata, Dept Biomed & Prevent, Fac Med, I-00173 Rome, Italy

[8] San Raffaele Cassino Nursing Home, I-03043 Cassino, FR, Italy

[9] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA

[10] Harvard Med Sch, Charlestown, MA 02129 USA

来源：

JOURNAL OF SPORT AND HEALTH SCIENCE | 2016年 / 5卷 / 04期

关键词：

ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEMENTIA;

D O I：

10.1016/j.jshs.2016.08.007

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：383 / 387

页数：5

共 50 条

[41] Uncovering the therapeutic potential of natural products with biomarker-guided screening
Kawamura, Akira
IDRUGS, 2010, 13 (05) : 321 - 324
[42] Phase II cancer clinical trials for biomarker-guided treatments
Jung, Sin-Ho
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (02) : 256 - 263
[43] Improving clinical trial efficiency by biomarker-guided patient selection
Ruud Boessen
Hiddo J Lambers Heerspink
Dick De Zeeuw
Diederick E Grobbee
Rolf HH Groenwold
Kit CB Roes
Trials, 15
[44] Biomarker-guided clinical decisions: for patients, health economists or neither?
Jensen, Jens-Ulrik
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (04) : 895 - 897
[45] Learning optimal biomarker-guided treatment policy for chronic disorders
Yang, Bin
Guo, Xingche
Loh, Ji Meng
Wang, Qinxia
Wang, Yuanjia
STATISTICS IN MEDICINE, 2024, 43 (14) : 2765 - 2782
[46] Improving clinical trial efficiency by biomarker-guided patient selection
Boessen, Ruud
Heerspink, Hiddo J. Lambers
De Zeeuw, Dick
Grobbee, Diederick E.
Groenwold, Rolf H. H.
Roes, Kit C. B.
TRIALS, 2014, 15
[47] Biomarker-guided translation of brain imaging into disease pathway models
Younesi, Erfan
Hofmann-Apitius, Martin
SCIENTIFIC REPORTS, 2013, 3
[48] Biomarker-guided clustering of Alzheimer's disease clinical syndromes
Toschi, Nicola
Lista, Simone
Baldacci, Filippo
Cavedo, Enrica
Zetterberg, Henrik
Blennow, Kaj
Kilimann, Ingo
Teipel, Stefan J.
dos Santos, Antonio Melo
Epelbaum, Stephane
Lamari, Foudil
Genthon, Remy
Habert, Marie-Odile
Dubois, Bruno
Floris, Roberto
Garaci, Francesco
Vergallo, Andrea
Hampel, Harald
Afshar, Mohammad
Aguilar, Lisi Flores
Akman-Anderson, Leyla
Arenas, Joaquin
Babiloni, Claudio
Baldacci, Filippo
Batrla, Richard
Benda, Norbert
Black, Keith L.
Bokde, Arun L. W.
Bonuccelli, Ubaldo
Broich, Karl
Cacciola, Francesco
Caraci, Filippo
Castrillo, Juan
Cavedo, Enrica
Ceravolo, Roberto
Chiesa, Patrizia A.
Corvol, Jean-Christophe
Cuello, Augusto Claudio
Cummings, Jeffrey L.
Depypere, Herman
Dubois, Bruno
Duggento, Andrea
Emanuele, Enzo
Escott-Price, Valentina
Federoff, Howard
Ferretti, Maria Teresa
Fiandaca, Massimo
Frank, Richard A.
Garaci, Francesco
Geerts, Hugo
NEUROBIOLOGY OF AGING, 2019, 83 : 42 - 53
[49] Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
Lista, Simone
Toschi, Nicola
Baldacci, Filippo
Zetterberg, Henrik
Blennow, Kaj
Kilimann, Ingo
Teipel, Stefan J.
Cavedo, Enrica
dos Santos, Antonio Melo
Epelbaum, Stephane
Lamari, Foudil
Dubois, Bruno
Floris, Roberto
Garaci, Francesco
Hampel, Harald
NEUROCHEMISTRY INTERNATIONAL, 2017, 108 : 355 - 360
[50] Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases
Lenahan, Cameron
Sanghavi, Rajvee
Huang, Lei
Zhang, John H.
FRONTIERS IN NEUROSCIENCE, 2020, 14

← 1 2 3 4 5 →